Transaction in Own Shares

Summary by AI BETAClose X

Worldwide Healthcare Trust PLC announced on October 8, 2025, the purchase of 1,642,087 Ordinary shares of 2.5p each at a price of 344.81 pence per share, which will be held in treasury. This purchase was made under the authority granted on October 1, 2025, to buy back up to 61,086,622 of its own shares. Following the transaction, the company holds 196,162,926 Ordinary shares in treasury. The total number of Ordinary shares in issue is 601,665,200, resulting in a total number of voting rights of 405,502,274. This figure of 405,502,274 should be used by shareholders to calculate their interest in the company under FCA rules.

Disclaimer*

 

For immediate release

8 October 2025

 

WORLDWIDE HEALTHCARE TRUST PLC

(the "Company")

 

 

MARKET PURCHASE OF COMPANY'S OWN SHARES

 

 

 

This notification is given, pursuant to the authority granted at a General Meeting of the Company held on 1 October 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 61,086,622.

 

The Company has purchased a market total of 1,642,087 Ordinary shares of 2.5p each in the capital of the Company today at a price of 344.81 pence per share. These shares will be held in treasury.

 

Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 196,162,926 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 405,502,274.

 

The figure of 405,502,274 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

For and on behalf of

Frostrow Capital LLP

Company Secretary

 

For further information, please contact:

 

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913

 




UK 100

Latest directors dealings